Aer Therapeutics, Inc.
Research Triangle Park, United States (US) · Health and Medical
Do your work at Aer Therapeutics, Inc.?
Claim this profile to manage your company.
Verified by Enterprise League
Data quality
Complete · Accuracy
Last verified
May 2026
Aer Therapeutics, Inc. is a Health and Medical company based in Research Triangle Park, United States (US), founded in 2014, with 2-10 employees. Aer Therapeutics, Inc.'s profile is verified on Enterprise League.
Overview
Aer Therapeutics is a clinical-stage biopharmaceutical company based in Research Triangle Park, North Carolina, focused on developing innovative therapies for muco-obstructive lung diseases.
We are dedicated to addressing a significant unmet need in the treatment of COPD and asthma, where mucus plugs frequently block airways, leading to reduced lung function and diminished quality of life.
AER-01, our lead therapeutic candidate, represents a novel approach – the first therapy designed to liquify mucus plugs by cleaving the chemical bonds that thicken mucus, effectively opening airways and restoring airflow.
Developed from groundbreaking research at UCSF, UCD, and Trinity College Dublin, and supported by over $18M in NIH grant funding, Aer Therapeutics is committed to transforming respiratory care and empowering patients to breathe freely. AER-01 is the first inhaled therapy developed to clear mucus blockages, helping to break the cycle of inflammation and restore the freedom to breathe.
We are dedicated to addressing a significant unmet need in the treatment of COPD and asthma, where mucus plugs frequently block airways, leading to reduced lung function and diminished quality of life.
AER-01, our lead therapeutic candidate, represents a novel approach – the first therapy designed to liquify mucus plugs by cleaving the chemical bonds that thicken mucus, effectively opening airways and restoring airflow.
Developed from groundbreaking research at UCSF, UCD, and Trinity College Dublin, and supported by over $18M in NIH grant funding, Aer Therapeutics is committed to transforming respiratory care and empowering patients to breathe freely. AER-01 is the first inhaled therapy developed to clear mucus blockages, helping to break the cycle of inflammation and restore the freedom to breathe.
Contact Details
info@aertherapeutics.com
Research Triangle Park, United States (US)
+1
Founded
2014
Company Type
Private Limited Company
Employees
2-10
Categories
Companies teams usually look at after Aer Therapeutics, Inc.
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.